Skip to main content

Closed

GLUE: Monte Rosa Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

57thpctl

Volume

6.31×avg

Market Cap

1.40BUSD

P/E Ratio

-8.9TTM

Div Yield

-ann

Monte Rosa Therapeutics, Inc.

GLUENASDAQ Global Select·USD·Closed

Monte Rosa Therapeutics, Inc.

GLUENASDAQ·USD·Closed

$16.52

−27.16%

$16.52

−$6.16 (27.16%)

52W Range

57thpctl

Volume

6.31×avg

Mkt Cap

1.40BUSD

P/E

-8.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings